N. Wald, H. Watt, and A. Hackshaw, Integrated Screening for Down's Syndrome Based on Tests Performed during the First and Second Trimesters, New England Journal of Medicine, vol.341, issue.7, pp.461-467, 1999.
DOI : 10.1056/NEJM199908123410701

K. Nicolaides, V. Heath, and S. Cicero, Increased fetal nuchal translucency at 11???14???weeks, Prenatal Diagnosis, vol.106, issue.4, pp.308-315, 2002.
DOI : 10.1002/pd.308

D. Wellesley, T. Boyle, J. Barber, and D. Howe, Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region, BMJ, vol.325, issue.7354, p.15, 2002.
DOI : 10.1136/bmj.325.7354.15

S. Ayme, N. Morichon, J. Goujard, and I. Nisand, Prenatal diagnosis in France, Eur J Hum Genet, vol.5, issue.1, pp.26-31, 1997.

D. Vigan, C. Vodovar, V. Verite, V. Dehe, S. Goujard et al., Current french practices for prenatal diagnosis of trisomy 21: a population-based study in Paris, 1992-97, Prenatal Diagnosis, vol.297, issue.12, pp.1113-1118, 1999.
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1113::AID-PD715>3.0.CO;2-5

V. Seror, N. Costet, and S. Ayme, Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women, J Gynecol Obstet Biol Reprod (Paris), vol.29, issue.5, pp.492-500, 2000.

C. Stoll, Y. Alembik, B. Dott, and M. Roth, Recent trends in the prevalence of Down syndrome in north-eastern France, Ann Genet, vol.37, issue.4, pp.179-183, 1994.

A. Robbins, S. Chao, and V. Fonseca, What's the Relative Risk? A Method to Directly Estimate Risk Ratios in Cohort Studies of Common Outcomes, Annals of Epidemiology, vol.12, issue.7, pp.452-454, 2002.
DOI : 10.1016/S1047-2797(01)00278-2

H. Cuckle, Down syndrome fetal loss rate in early pregnancy, Prenatal Diagnosis, vol.14, issue.12, pp.1177-1179, 1999.
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1177::AID-PD714>3.0.CO;2-N

G. Bréart, Delayed childbearing, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.75, issue.1, pp.71-73, 1997.
DOI : 10.1016/S0301-2115(97)00190-5

N. Leporrier, M. Herrou, R. Morello, and P. Leymarie, Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening, BJOG: An International Journal of Obstetrics and Gynaecology, vol.21, issue.7, pp.18-21, 2003.
DOI : 10.1002/(SICI)1097-0223(199912)19:12<1175::AID-PD706>3.0.CO;2-K

B. Blondel, J. Norton, C. Du-mazaubrun, and G. Bréart, pour la coordination nationale des enquêtes nationales périnatales. Trends in main indicators of perinatal health in France between 1995 and 1998. Results from the National Perinatal Surveys, J Gynecol Obstet Biol Reprod (Paris), vol.30, issue.16, pp.552-564, 2001.

D. Vigan, C. Vodovar, V. Goujard, J. Garel, M. Vayssiere et al., Mothers??? knowledge of screening for trisomy 21 in 1999: a survey in Paris maternity units, European Journal of Obstetrics & Gynecology and Reproductive Biology, vol.104, issue.1, pp.14-20, 2002.
DOI : 10.1016/S0301-2115(01)00559-0

J. Martin, B. Hamilton, S. Ventura, F. Menacker, and M. Park, Births: final data for, Natl Vital Stat Rep, vol.50, issue.5, pp.1-101, 2000.

J. Haddow, G. Palomaki, G. Knight, G. Cunningham, L. Lustig et al., Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening, New England Journal of Medicine, vol.330, issue.16, pp.1114-1122, 1994.
DOI : 10.1056/NEJM199404213301603

J. Egan, P. Benn, A. Borgida, J. Rodis, W. Campbell et al., Efficacy of screening for fetal Down syndrome in the United States from, Obstet Gynecol, vol.96, issue.206, pp.979-985, 1974.

B. Khoshnood, B. Blondel, D. Vigan, C. Bréart, and G. , Effects of maternal age and education on the pattern of prenatal testing: Implications for the use of antenatal screening as a solution to the growing number of amniocenteses, American Journal of Obstetrics and Gynecology, vol.189, issue.5, pp.1336-1342, 2003.
DOI : 10.1067/S0002-9378(03)00643-4

T. Marteau and H. Drake, Attributions for disability: The influence of genetic screening, Social Science & Medicine, vol.40, issue.8, pp.1127-1132, 1995.
DOI : 10.1016/0277-9536(94)00180-2

T. Cheffins, A. Chan, E. Haan, E. Ranieri, R. Ryall et al., The impact of maternal serum screening on the birth prevalence of Down's syndrome and the use of amniocentesis and chorionic villus sampling in South Australia, BJOG: An International Journal of Obstetrics and Gynaecology, vol.327, issue.12, pp.1453-1459, 2000.
DOI : 10.1016/0140-6736(92)93293-V